| 000 | 018600000a22003490004500 | ||
|---|---|---|---|
| 003 | EG-GICUC | ||
| 005 | 20250223025335.0 | ||
| 008 | 080616s2008 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GICUC _beng _cEG-GICUC |
||
| 041 | 0 | _aEng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.28.M.Sc.2008.Sh.A | ||
| 100 | 0 | _aShereen Abdelmonem Mohamed | |
| 245 | 1 | 0 |
_aAntiphospholipid antibodies in Egyptian systemic lupus erythematosus patients / _cShereen Abdelmonem Mohamed ; Supervised Samia Salah Eldin , Nora Elsaeed Badawy , Hala Mohamed Lotfy |
| 246 | 1 | 5 | _aالاجسام المضادة للدهون الفوسفاتية فى الاطفال المصريين المصابين بمرض الذئبة الحمراء |
| 260 |
_aCairo : _bShereen Abdelmonem Mohamed , _c2008 |
||
| 300 |
_a152p. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty Of Medicine - Department Of Pediatrics | ||
| 520 | _aAntiphospholipid syndrome (ABS) is classified into primary and secondary.Systemic lupus erythematosus (SLE) is the most common cause of secondary APS.the prevalence of APLAs either LA or ACLAs in patients with SLE is high (Roubey , 2004) .objective : this study was designed to determine the frequency of anti - phospholipid antibodies (aCL igG , aCL igM and lA) in pediatric SLE patients and their correlation with the associated clinical manifestations in Egyptian children | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAntiphospholipid antibodies | |
| 653 | 4 | _aChildren | |
| 653 | 4 | _aSystemic lupus erythematosus | |
| 700 | 0 |
_aHala Mohamed Lotfy , _eSupervisor |
|
| 700 | 0 |
_aNora Elsaeed Badawy , _eSupervisor |
|
| 700 | 0 |
_aSamia Salah Eldin , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aMustafa _eRevisor |
||
| 905 |
_aNoha _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c10860 _d10860 |
||